Not recruiting
Neuroendocrine carcinoma metastatic
Not recruitingInvestigationalNo placebo
Study of AdVince (Modified Adenovirus) Treatment Through Hepatic Artery Injection in Patients with Advanced Neuroendocrine Neoplasms
InvestigationalNo placebo
- Disease:Neuroendocrine carcinoma metastatic
- Substances:Human Adenovirus C Serotype 5 With E1 Gene Controlled By Chromogranin A Promoter And Hexon Modified With Protein Transduction Domain Motif
Countries:
Sweden
Sweden- Participants:18–64 years · 65+ years
- Substances:Human Adenovirus C Serotype 5 With E1 Gene Controlled By Chromogranin A Promoter And Hexon Modified With Protein Transduction Domain Motif













